{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:01:12Z","timestamp":1792425672548,"version":"4.5.0"},"reference-count":24,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,2,1]]},"DOI":"10.1210\/jcem.83.2.4556","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:02:56Z","timestamp":1389200576000},"page":"374-378","source":"Crossref","is-referenced-by-count":291,"title":["Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients"],"prefix":"10.1210","volume":"83","author":[{"given":"Roger","family":"Abs","sequence":"first","affiliation":[{"name":"Department of Endocrinology, University Hospital (R.A., K.V.A.), Antwerp"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Verhelst","sequence":"additional","affiliation":[{"name":"Middelheim Hospital (J.V., C.M.), Antwerp"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Maiter","sequence":"additional","affiliation":[{"name":"Ho\u0302pital Saint-Luc (D.M.), Brussels"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristien","family":"Van Acker","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital (R.A., K.V.A.), Antwerp"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Nobels","sequence":"additional","affiliation":[{"name":"Onze Lieve Vrouw Hospital (F.N.), Aalst"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Coolens","sequence":"additional","affiliation":[{"name":"Salvator Hospital (J.-L.C.), Hasselt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mahler","sequence":"additional","affiliation":[{"name":"Middelheim Hospital (J.V., C.M.), Antwerp"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Beckers","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire (A.B.), Lie\u0300ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041117525143900_R1","first-page":"3395","article-title":"Recent advances in pathogenesis, diagnosis, and management of acromegaly.","volume":"80","author":"Melmed","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117525143900_R2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0889-8529(18)30463-8","article-title":"Pathology of pituitary tumors.","volume":"16","author":"Kovacs","year":"1987","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041117525143900_R3","first-page":"293","article-title":"An audit of outcome of treatment in acromegaly.","volume":"86","author":"Bates","year":"1993","journal-title":"Q J Med"},{"key":"2019041117525143900_R4","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1056\/NEJM199004053221405","article-title":"Acromegaly.","volume":"322","year":"1990","journal-title":"N Engl J Med"},{"key":"2019041117525143900_R5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0889-8529(18)30208-1","article-title":"Surgical management of acromegaly.","volume":"21","author":"Fahlbusch","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041117525143900_R6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0889-8529(18)30209-3","article-title":"Radiation therapy of acromegaly.","volume":"21","author":"Eastman","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041117525143900_R7","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/archinte.1991.00400080073013","article-title":"Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicentre Acromegaly Study Group.","volume":"151","author":"Vance","year":"1991","journal-title":"Arch Intern Med"},{"key":"2019041117525143900_R8","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/0003-4819-117-9-711","article-title":"Octreotide treatment of acromegaly. A randomised, multicentre study.","volume":"117","author":"Ezzat","year":"1992","journal-title":"Ann Intern Med"},{"key":"2019041117525143900_R9","first-page":"18","article-title":"Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide.","volume":"82","author":"Caron","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117525143900_R10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1210\/jcem.82.1.3572","article-title":"Sandostatin LAR in acromegalic patients: long term treatment.","volume":"82","author":"Kvistborg Fl\u00f8gstad","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117525143900_R11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jcem-64-3-447","article-title":"Medical treatment of acromegaly with SMS 201\u2013995, a somatostatin analog: a comparison with bromocriptine.","volume":"64","author":"Chiodini","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117525143900_R12","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jcem-70-5-1254","article-title":"A randomised study of SMS 201\u2013995 vs. bromocriptine treatment in acromegaly: clinical and biochemical effects.","volume":"70","author":"Halse","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117525143900_R13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhoea.","volume":"331","author":"Webster","year":"1994","journal-title":"N Engl J Med"},{"key":"2019041117525143900_R14","first-page":"2338","article-title":"Treatment of prolactin-secreting macroadenoma with the once-weekly dopamine agonist cabergoline.","volume":"81","author":"Biller","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117525143900_R15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2265.1997.1300952.x","article-title":"Treatment of macroprolactinoma with cabergoline: a study of 85 patients.","volume":"46","author":"Ferrari","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041117525143900_R16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1530\/acta.0.1030446","article-title":"The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.","volume":"103","author":"Lamberts","year":"1983","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041117525143900_R17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3171\/jns.1989.70.4.0561","article-title":"Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurements in acromegaly.","volume":"70","author":"Losa","year":"1989","journal-title":"J Neurosurg"},{"key":"2019041117525143900_R18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0889-8529(18)30210-X","article-title":"Treatment of acromegaly with dopamine agonists.","volume":"121","author":"Jaffe","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041117525143900_R19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/acta.0.1280389","article-title":"CV 205\u2013502 in acromegaly.","volume":"128","author":"Chiodini","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041117525143900_R20","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/BF03347120","article-title":"Evaluation of a repeatable depot-bromocriptine preparation (Parlodel LAR) for the treatment of acromegaly.","volume":"14","author":"Plockinger","year":"1991","journal-title":"J Endocrinol Invest"},{"key":"2019041117525143900_R21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2265.1988.tb03695.x","article-title":"Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients.","volume":"29","author":"Ferrari","year":"1988","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041117525143900_R22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1210\/jcem.82.2.3648","article-title":"Effect of different dopaminergic agents in the treatment of acromegaly.","volume":"82","author":"Colao","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117525143900_R23","first-page":"745","volume":"46","author":"Jackson","year":"1997"},{"key":"2019041117525143900_R24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1183\/09031936.93.05020263","article-title":"Pleuropulmonary changes during treatment of Parkinson\u2019s disease with a long-acting ergot derivative, cabergoline.","volume":"5","author":"Frans","year":"1992","journal-title":"Eur Respir J"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/83\/2\/374\/9228964\/jcem0374.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T14:52:35Z","timestamp":1688914355000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/83\/2\/374\/2865170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2,1]]},"references-count":24,"aliases":["10.1210\/jc.83.2.374"],"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.83.2.4556","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2,1]]}}}